SCHEMBL1823997

SCHEMBL1823997

CCC(Nc1cc(C)cc(C)c1)S(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NR3C1 P04150 3/20 0.36
PGR P06401 3/20 0.36
NR3C2 P08235 3/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27617207 0.83 GAA (0.46) HTTNPSR1CYP1A2CYP3A4HPGD
SCHEMBL9551532 0.82 GAA (0.45) HTTNPSR1CYP1A2CYP3A4HPGD
SCHEMBL8440991 0.79 TDP1 (0.35) HTTCA1CA2LMNA
SCHEMBL8435611 0.78 ACP1 (0.36) CA12CA1CA2CA9CYP3A4
SCHEMBL1012824 0.78 KMT2A (0.46) HTTCYP1A2CYP3A4LMNAGAA
SCHEMBL8439787 0.78 MEP1B (0.38) HTTCYP1A2CYP3A4GAAPOLB
SCHEMBL1009042 0.76 TDP1 (0.42) CA12CA1CA2CA9CYP3A4
SCHEMBL4614536 0.74 LMNA (0.34) HTTCA12CA1CA2CA9
SCHEMBL21779673 0.69 ALDH1A1 (0.60) HTTNPSR1CYP1A2CYP3A4SYK
SCHEMBL27617593 0.68 CA1 (0.48) CA12CA1CA2CA9POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7070462-A None JP disclosed
US-12264356-B2 Method for determining sensitivity to SGLT2 inhibitor and sensitivity marker for SGLT2 inhibitor NIHON UNIVERSITY (JP) 2025-04-01 US disclosed
US-20200347458-A1 METHOD FOR DETERMINING SENSITIVITY TO SGLT2 INHIBITOR AND SENSITIVITY MARKER FOR SGLT2 INHIBITOR NIHON UNIVERSITY (JP) 2020-11-05 US disclosed
CN-105164273-B The assay method of mankind's pancreatic lipase activity 旭化成制药株式会社 2017-09-12 CN disclosed
EP-2319937-B1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KK (JP) 2016-01-27 EP disclosed
US-8883439-B2 Blood component measurement method utilizing hemolyzed whole blood, and kit for the method NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2014-11-11 US disclosed
US-20110165608-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-07 US disclosed
EP-2319937-A1 BLOOD COMPONENT MEASUREMENT METHOD UTILIZING HEMOLYZED WHOLE BLOOD, AND KIT FOR THE METHOD Nippon Kayaku Kabushiki Kaisha (JP) 2011-05-11 EP disclosed
JP-H0770462-A WATER-SOLUBLE METHYLENEBISDIALKYLANILINE DERIVATIVE, SALTS THEREOF AND COMPOSITION FOR DETERMINING PEROXIDE SUBSTANCE USING THE SAME DERIVATIVE AND SAILS DOUJIN KAGAKU KENKYUSHO:KK 1995-03-14 JP disclosed